PUBLIC COMPANY
save$IXHLIncannex Healthcare Inc.
$IXHLNorwest Nsw, AUupdated 2mo ago
community read0 votes
pipeline
15
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(15)
view full pipeline →pipeline depth15 products
13Preclinical1Phase 11Phase 3
Phase 3
(acetazolamide + dronabinol)
Obstructive Sleep Apnea
Phase 1Medchew Dronabinol
Chemotherapy Induced Nausea and Vomiting
Preclinical(cannabidiol + dronabinol)
Restless Legs Syndrome
Preclinical(cannabidiol + isoflurane)
Traumatic Brain Injury
Preclinical(cannabidiol + nicotine)
Smoking Cessation
PreclinicalAPIRx-1505
Crohn's Disease (Regional Enteritis)
PreclinicalAPIRx-1701
Glaucoma
PreclinicalAPIRx-1702
Keratoconjunctivitis Sicca (Dry Eye)
PreclinicalCanChew RX
Inflammatory Bowel Disease
PreclinicalCannQuit-O
Opium (Opioid) Addiction
PreclinicalChewell
Substance (Drug) Abuse
PreclinicalMedchew-1502
Parkinson's Disease
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.
- phase3RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA
- phase2Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis
- phase1Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugs
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 57m ago
Found something off?
comments(0)
5-min edit window · permanent after that